Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
49,662,791
-
Share change
-
-447,701
-
Total reported value
-
$627,746,190
-
Price per share
-
$12.64
-
Number of holders
-
33
-
Value change
-
-$7,334,893
-
Number of buys
-
14
-
Number of sells
-
14
Institutional Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q4 2017
As of 31 Dec 2017,
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,662,791 shares.
The largest 10 holders included
QVT Financial LP, BB BIOTECH AG, RA CAPITAL MANAGEMENT, LLC, NovaQuest Capital Management, L.L.C., BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., NORGES BANK, EVENTIDE ASSET MANAGEMENT, LLC, Tekla Capital Management LLC, and D. E. Shaw & Co., Inc..
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.